Crispr Therapeutics AGEigentümerstruktur
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 46.54 USD | 78,48 USD | 44,12 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 86,211 USD | 12 | 5 | 10 | 0 | 1 |
| #Shares | Short [%] | Short Ratio |
| 98.484.128 | 22,97 | 11,26 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Crispr Therapeutics AG
Mitarbeiter 393
Handelsplatz NASDAQ
Ticker Symbol CRSP
IPO Datum 2016-10-19
Adresse Baarerstrasse 14, Zug, Switzerland, 6300
Webseite https://www.crisprtx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Samarth Kulkarni Ph.D. | CEO & Chairman |
| 2 | Dr. Raju Yashaswi Prasad Ph.D. | Chief Financial Officer |
| 3 | Mr. James R. Kasinger J.D. | General Counsel & Secretary |
| 4 | Dr. Naimish Patel C.M., M.D. | Chief Medical Officer |
| 5 | Mr. Shaun Foy CFA | Co-Founder |
| 6 | Dr. Emmanuelle Marie Charpentier Ph.D. | Co-Founder & Scientific Advisory Board Member |
| 7 | Dr. Craig C. Mello Ph.D. | Scientific Founder & Advisory Board Member |
| 8 | Dr. Chad A. Cowan Ph.D. | Scientific Founder |
| 9 | Dr. Matthew Porteus M.D., Ph.D. | Scientific Founder & Advisory Board Member |
| 10 | Dr. Daniel G. Anderson Ph.D. | Scientific Founder & Advisory Board Member |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | ARK Investment Management LLC | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | Orbis Allan Gray Ltd | 0,00% | 0,00 Mio. USD |
| 4 | Capital World Investors | 0,00% | 0,00 Mio. USD |
| 5 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 6 | GSK PLC | 0,00% | 0,00 Mio. USD |
| 7 | T. Rowe Price Investment Management,Inc. | 0,00% | 0,00 Mio. USD |
| 8 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 9 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 10 | SR ONE CAPITAL MANAGEMENT, LP | 0,00% | 0,00 Mio. USD |
| 11 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 12 | Amova Asset Management Americas, Inc | 0,00% | 0,00 Mio. USD |
| 13 | Sumitomo Mitsui Trust Group Inc | 0,00% | 0,00 Mio. USD |
| 14 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 15 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 16 | EcoR1 Capital, LLC | 0,00% | 0,00 Mio. USD |
| 17 | Capital Research & Mgmt Co - Division 3 | 0,00% | 0,00 Mio. USD |
| 18 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 19 | NEA Management Company, LLC | 0,00% | 0,00 Mio. USD |
| 20 | Charles Schwab Investment Management Inc | 0,00% | 0,00 Mio. USD |